Abans Holdings Ltd IPO

Incorporated in 1983, Kolkata-based Tarsons Products manufactures laboratory products that are used in various research organisations, pharmaceutical companies, academia institutes, hospitals and diagnostic centres.

The company plans to go public and here’s all you need to know about this IPO.

Here’s the consolidated financial information for the last three years:

• An integrated financial services platform
• Strong human capital and organizational culture
• Global exposure providing innovative financial products
• Strong relationships with clients and market participants
• Standardized operating procedures and efficient use of technology

• The continuing impacts of COVID-19, or the impact of outbreaks of any other severe communicable disease are highly unpredictable, could be significant and may adversely affect its business, operations and future financial performance.
• The Company, its Promoter /Director, its Subsidiaries and its Group Companies are parties to certain legal proceedings. Any adverse decision in such proceedings may have a material adverse effect on its business, results of operations and financial condition.
• One of its subsidiaries namely, Abans Commodities (I) Private Limited is involved in a proceeding before SEBI regarding allegations of participation /facilitation by it of pair-contracts as a trading member/clearing member. Any adverse outcome in the matter would have an adverse effect on the operations of Abans Commodities (I) Private Limited and the reputation of the Abans Group, which in turn could have an adverse impact on its business, financial condition and results of operations.
• The company require certain approvals and licenses in the ordinary course of business and are required to comply with certain rules and regulations to operate its business, and the failure to obtain, retain and renew such approvals and licences in timely manner or comply with such rules and regulations or at all may adversely affect its operations.
• General economic and market conditions in India and globally could have a material adverse effect on its business, financial condition, cash flows, results of operations and prospects.

• Using technology to create greater scalability
• Continue to expand its lines of business into complementary businesses
• Augment its fund based capacities in order to scale up business operations
• Using technology to create greater scalability
• Continue to expand its lines of business into complementary businesses